Literature DB >> 33049052

Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement.

Timothy Carll1, Anand Patel2, Benjamin Derman2, Elizabeth Hyjek1, Angela Lager1, Pankhuri Wanjari1, Jeremy Segal1, Olatoyosi Odenike2, Shiraz Fidai3, Daniel Arber1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 33049052      PMCID: PMC7556145          DOI: 10.1182/bloodadvances.2019001282

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


× No keyword cloud information.
  25 in total

Review 1.  ETV6 fusion genes in hematological malignancies: a review.

Authors:  Etienne De Braekeleer; Nathalie Douet-Guilbert; Frédéric Morel; Marie-Josée Le Bris; Audrey Basinko; Marc De Braekeleer
Journal:  Leuk Res       Date:  2012-05-12       Impact factor: 3.156

2.  STAR: ultrafast universal RNA-seq aligner.

Authors:  Alexander Dobin; Carrie A Davis; Felix Schlesinger; Jorg Drenkow; Chris Zaleski; Sonali Jha; Philippe Batut; Mark Chaisson; Thomas R Gingeras
Journal:  Bioinformatics       Date:  2012-10-25       Impact factor: 6.937

3.  Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation.

Authors:  F Yagasaki; D Wakao; Y Yokoyama; Y Uchida; I Murohashi; H Kayano; M Taniwaki; A Matsuda; M Bessho
Journal:  Cancer Res       Date:  2001-12-01       Impact factor: 12.701

4.  High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).

Authors:  Sarah M Larson; Nicholas P Campbell; Dezheng Huo; Andrew Artz; Yanming Zhang; Devika Gajria; Margaret Green; Howie Weiner; Christopher Daugherty; Olatoyosi Odenike; Lucy A Godley; Elizabeth Hyjek; Sandeep Gurbuxani; Michael Thirman; Dorothy Sipkins; Koen Van Besien; Richard A Larson; Wendy Stock
Journal:  Leuk Lymphoma       Date:  2012-03

5.  Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia.

Authors:  M S Khodadoust; B Luo; B C Medeiros; R C Johnson; M D Ewalt; A S Schalkwyk; C D Bangs; A M Cherry; S Arai; D A Arber; J L Zehnder; J Gotlib
Journal:  Leukemia       Date:  2015-06-09       Impact factor: 11.528

Review 6.  Germline ETV6 mutations and predisposition to hematological malignancies.

Authors:  Simone Feurstein; Lucy A Godley
Journal:  Int J Hematol       Date:  2017-05-29       Impact factor: 2.490

7.  Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation.

Authors:  T R Golub; G F Barker; M Lovett; D G Gilliland
Journal:  Cell       Date:  1994-04-22       Impact factor: 41.582

8.  BMI-1 expression is enhanced through transcriptional and posttranscriptional regulation during the progression of chronic myeloid leukemia.

Authors:  Joyeeta Bhattacharyya; Keichiro Mihara; Shin'ichiro Yasunaga; Hideo Tanaka; Masaharu Hoshi; Yoshihiro Takihara; Akiro Kimura
Journal:  Ann Hematol       Date:  2008-09-10       Impact factor: 3.673

9.  Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia.

Authors:  Leila Noetzli; Richard W Lo; Walter H A Kahr; Christopher C Porter; Jorge Di Paola; Alisa B Lee-Sherick; Michael Callaghan; Patrizia Noris; Anna Savoia; Madhvi Rajpurkar; Kenneth Jones; Katherine Gowan; Carlo Balduini; Alessandro Pecci; Chiara Gnan; Daniela De Rocco; Michael Doubek; Ling Li; Lily Lu; Richard Leung; Carolina Landolt-Marticorena; Stephen Hunger; Paula Heller; Arthur Gutierrez-Hartmann; Liang Xiayuan; Fred G Pluthero; Jesse W Rowley; Andrew S Weyrich
Journal:  Nat Genet       Date:  2015-03-25       Impact factor: 38.330

10.  AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance.

Authors:  Thomas O'Hare; William C Shakespeare; Xiaotian Zhu; Christopher A Eide; Victor M Rivera; Frank Wang; Lauren T Adrian; Tianjun Zhou; Wei-Sheng Huang; Qihong Xu; Chester A Metcalf; Jeffrey W Tyner; Marc M Loriaux; Amie S Corbin; Scott Wardwell; Yaoyu Ning; Jeffrey A Keats; Yihan Wang; Raji Sundaramoorthi; Mathew Thomas; Dong Zhou; Joseph Snodgrass; Lois Commodore; Tomi K Sawyer; David C Dalgarno; Michael W N Deininger; Brian J Druker; Tim Clackson
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

View more
  4 in total

1.  ETV6-FLT3-positive myeloid/lymphoid neoplasm with eosinophilia presenting in an infant: an entity distinct from JMML.

Authors:  Barbara Spitzer; Filemon S Dela Cruz; Glorymar D Ibanez Sanchez; Yanming Zhang; Wenbin Xiao; Ryma Benayed; Alina Markova; M Irene Rodriguez-Sanchez; Nancy Bouvier; Mikhail Roshal; Andrew L Kung; Neerav Shukla
Journal:  Blood Adv       Date:  2021-04-13

Review 2.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.

Authors:  Joseph D Khoury; Eric Solary; Oussama Abla; Yassmine Akkari; Rita Alaggio; Jane F Apperley; Rafael Bejar; Emilio Berti; Lambert Busque; John K C Chan; Weina Chen; Xueyan Chen; Wee-Joo Chng; John K Choi; Isabel Colmenero; Sarah E Coupland; Nicholas C P Cross; Daphne De Jong; M Tarek Elghetany; Emiko Takahashi; Jean-Francois Emile; Judith Ferry; Linda Fogelstrand; Michaela Fontenay; Ulrich Germing; Sumeet Gujral; Torsten Haferlach; Claire Harrison; Jennelle C Hodge; Shimin Hu; Joop H Jansen; Rashmi Kanagal-Shamanna; Hagop M Kantarjian; Christian P Kratz; Xiao-Qiu Li; Megan S Lim; Keith Loeb; Sanam Loghavi; Andrea Marcogliese; Soheil Meshinchi; Phillip Michaels; Kikkeri N Naresh; Yasodha Natkunam; Reza Nejati; German Ott; Eric Padron; Keyur P Patel; Nikhil Patkar; Jennifer Picarsic; Uwe Platzbecker; Irene Roberts; Anna Schuh; William Sewell; Reiner Siebert; Prashant Tembhare; Jeffrey Tyner; Srdan Verstovsek; Wei Wang; Brent Wood; Wenbin Xiao; Cecilia Yeung; Andreas Hochhaus
Journal:  Leukemia       Date:  2022-06-22       Impact factor: 12.883

3.  Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors.

Authors:  Wei Hong; Ang Li; Yanhong Liu; Xiangjun Xiao; David C Christiani; Rayjean J Hung; James McKay; John Field; Christopher I Amos; Chao Cheng
Journal:  Cancer Res       Date:  2021-11-23       Impact factor: 13.312

4.  Small RNA-Seq Reveals Similar miRNA Transcriptome in Children and Young Adults with T-ALL and Indicates miR-143-3p as Novel Candidate Tumor Suppressor in This Leukemia.

Authors:  Małgorzata Dawidowska; Natalia Maćkowska-Maślak; Monika Drobna-Śledzińska; Maria Kosmalska; Roman Jaksik; Donata Szymczak; Małgorzata Jarmuż-Szymczak; Alicja Sadowska-Klasa; Marzena Wojtaszewska; Łukasz Sędek; Tomasz Wróbel; Jan Maciej Zaucha; Tomasz Szczepański; Krzysztof Lewandowski; Sebastian Giebel; Michał Witt
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.